Changing the World’s Perspective
on Breast Imaging
Our Mission
Our mission is to create a revolution in medical imaging through our advanced Computed Tomography technology, optimizing early disease detection, diagnosis, intervention and treatment. Our hope is to be able to improve survival rates and outcomes for millions of patients.
Our Vision
Koning Revolutionary Technology
Dr. Ning founds Koning with exclusive license from University of Rochester
Koning Corporation is founded as a Delaware C corporation and receives exclusive license from the University of Rochester for Cone Beam CT and Cone Beam Breast CT technology.
Designs and starts clinical trials of first KBCT prototype
With the scientific and engineering experience from the previous cone beam CT systems, Dr. Ning and his group designed the first commercial grade Cone Beam Breast CT specifically for breast imaging.
This is the first time true three-dimensional, isotropic tomography images were introduced to breast imaging.
Secures $3.2M of US funding to accelerate development
First clinical paper published showing positive results from 2006-2008 clinical trials
Recieves CE mark clearance
Commercial version of KBCT approved by FDA
Commercial version of KBCT approved by CFDA
Regulatory approval recieved for Canada, Singapore, Australia, Thailand, and Qatar